Further studies which define CD180 signaling behaviour at a greater resolution will aid in developing CD180 as a prognostic biomarker and may help to highlight potential therapeutic avenues, particularly in CLL, SLE and cardiovascular pathologies. Here, CD180 is linked to systemic lupus erythematosus.